QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2022    专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2022 作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi 收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23 Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)  apatinib  case report   High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2022 作者:  Zhang, Shengjie;  Wang, Yi;  Yuan, Li;  Hu, Can;  Xu, Zhiyuan 收藏  |  浏览/下载：20/0  |  提交时间：2022/12/22 Gastric cancer  ceramide synthase 5 (CerS5)  prognosis  The Cancer Genome Atlas (TCGA)  Asian Cancer Research Group (ACRG)   Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2022, 卷号: 11 作者:  Zhang, Yanqiang;  Xu, Xiaoqing;  Hu, Can;  Du, Yian;  Ding, Guangyu 收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23 Gastric cancer  HER2-positive  conversion therapy   CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer 期刊论文 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Yuan, Li;  Xu, Jingli;  Shi, Yunfu;  Jin, Zhiyuan;  Bao, Zhehan 收藏  |  浏览/下载：13/0  |  提交时间：2022/12/23 gastric cancer  cd3d  tumor infiltrating lymphocytes (TILs)  prognosis  PD-L1